Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study.
Yutaka YamamotoHiroyasu YamashiroUhi TohNaoto KondoRikiya NakamuraMasahiro KashiwabaMasato TakahashiKoichiro TsugawaTakashi IshikawaTakahiro NakayamaShoichiro OhtaniToshimi TakanoTomomi FujisawaTatsuya ToyamaHidetoshi KawaguchiKojiro MashinoYuichi TaninoSatoshi MoritaMasakazu ToiShinji OhnoPublished in: Breast cancer (Tokyo, Japan) (2020)
Trial no. UMIN000009086.